$INJ — Injective’s Nasdaq ETF nod feels like the big‑ticket that finally gives the coin some institutional heft, and the 9.342% surge in the last 24 hrs backs that hype. The price is hovering just below the 8.196 swing resistance, so a short‑term test could be a clean confirmation of the narrative that the listing will lift the token. With the ETF approval fresh, the narrative isn’t a stretch – it’s the kind of catalyst that usually moves markets, and the recent rally shows traders are already buying in. So the story looks convincing right now, not ahead of the evidence.